Ozempic users face more stigma than people who don't lose weight: study

Key Points:

• New research reveals that individuals who lose weight using GLP-1 drugs like Ozempic or Wegovy face greater social stigma and negative judgment compared to those who lose weight through diet and exercise or do not lose weight at all.
• The study involved over 600 participants evaluating a fictional person's personality traits based on their weight loss method, finding that GLP-1 users were rated more harshly and socially penalized.
• Despite the rapid increase in GLP-1 usage for weight loss and its effectiveness, many users discontinue the drugs due to cost, side effects, or reluctance to maintain long-term use, often regaining weight quickly after stopping.
• A second experiment showed that people who regain weight are viewed negatively regardless of how the weight was initially lost, highlighting the pervasive stigma around weight regain in general.
• The stigma around GLP-1 drugs stems from perceptions that using medication is an "easy way out," which can lead to secrecy among users and negatively impact mental and physical health by discouraging open communication and healthcare seeking.